MedTrace Logo

Effects of ACEI on Bone Turnover

NCT02377440 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2015-12-04

No results posted yet for this study

Summary

The investigators hypothesize that older persons (≥45 years) treated with ACEI for HTN control will have: i) improved status of bone turnover (decreased P1NP and CTX), and ii) decreased levels of RANKL and RANKL/OPG, compared to those not treated with ACEI and not using RAS-related medications

Conditions

  • Bone Turnover Status in Hypertensive Patients

Sponsors & Collaborators

  • National Aeronautics and Space Administration (NASA)

    collaborator FED

  • The University of Texas Health Science Center, Houston

    lead OTHER

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02377440 on ClinicalTrials.gov